https://techpapersworld.com/wp-content/uploads/2022/11/Click-Therapeutics-Announces-Participation-1280x720.jpg

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that company management will participate in the following investor conferences in November and December. Jefferies London Healthcare Conference, November 15-17, 2022: David Benshoof Klein, Co-Founder and CEO, and Randall Stanicky, Chief Financial Officer, will participate in one-on-one meetings. BTIG Digital Health Forum, November 21, 2022: Richard DeNunzio, Chief Commercial Officer, will participate in a digital therapeutics panel discussion: “The Path Forward for Prescription...